首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Characterization and in vitro evaluation of spherulites as sequestering vesicles with potential application in drug detoxification
【24h】

Characterization and in vitro evaluation of spherulites as sequestering vesicles with potential application in drug detoxification

机译:作为螯合小球的球晶的表征和体外评价在药物排毒中的潜在应用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of the present investigation was to prepare and characterize lecithin spherulites as parenteral drug sequestering agents with potential application in the treatment of drug overdose and chemical poisoning. The spherulites (similar to 200 nm) obtained by controlled hydration and shearing of lipid-alcohol mixtures, revealed unexpected differences in the physical properties of the bilayer when compared to liposomes. Differential scanning calorimetry, 31-phosphorus nuclear magnetic resonance, and pH-sensitive pyranine steady-state fluorescence studies indicated that although spherulites retained the typical bilayer conformation, the arrangement of the phospholipid molecules was perturbed relative to native liposome bilayer. The loosened packing of the phospholipids in bilayers was strongly supported by the relative ease with which spherulites lost the established pH-gradient. This permeability problem was overcome via incorporation of cholesterol in the bilayer. Subsequently, albumin/ buffer components were encapsulated in these spherulites and the drug sequestration potential for detoxification application was examined. Citrate pH-gradient spherulites accumulated 75% of external haloperidol while those loaded with similar to 20% (w/w) albumin were able to. take up 45% of haloperidol and 91-95% of taxanes (docetaxel and paclitaxel). In cytotoxicity studies, the competitive internalization of docetaxel by albumin-loaded spherulites resulted in an increase of the IC50 value for the free drug. Thus, the spherulite technology could be a versatile approach for actively sequestering toxins in the blood and for reducing the adverse effects by altering the pharmacokinctics and biodistribution of overdosed drugs. (c) 2006 Elsevier B.V. All rights reserved.
机译:本研究的目的是制备和表征卵磷脂球蛋白作为肠胃外药物螯合剂,在治疗药物过量和化学中毒方面具有潜在的应用前景。与脂质体相比,通过脂质和酒精混合物的水合作用和剪切作用获得的球晶(约200 nm)显示出双层物理性能的出乎意料的差异。差示扫描量热法,31磷核磁共振和pH敏感的吡喃稳态荧光研究表明,尽管球晶保留了典型的双层构象,但磷脂分子的排列相对于天然脂质体双层却受到干扰。相对容易的球晶失去建立的pH梯度,这强烈支持了双层中磷脂的松散堆积。通过在双层中掺入胆固醇克服了这种渗透性问题。随后,将白蛋白/缓冲液成分封装在这些球晶中,并检查了用于解毒的药物螯合潜力。柠檬酸盐pH梯度球晶累积了75%的外部氟哌啶醇,而那些负载了类似20%(w / w)白蛋白的球蛋白则能够。占氟哌啶醇的45%和紫杉烷(多西他赛和紫杉醇)的91-95%。在细胞毒性研究中,多西他赛被载有白蛋白的球晶竞争性内化导致游离药物的IC50值增加。因此,球晶技术可以成为一种多用途的方法,可以通过隔离过量药物的药代动力学和生物分布来主动隔离血液中的毒素并减少不良影响。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号